Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Receives CLIA Certification, Massachusetts Licensure for Clinical Sequencing

NEW YORK (GenomeWeb News) – Beckman Coulter said after the close of the market on Tuesday that it has received CLIA certification and Massachusetts State Licensure, allowing its genomics operations to begin accepting clinical samples for genetic sequencing.

As a result, Beckman Coulter Genomics will be able to provide sequencing results to doctors for the treatment, diagnosis and prevention of disease in patients, it said.

Beckman said that the certification "paves the way" for the detection of BRAF exon 11 and exon 15 for mutations using PCR-based DNA Sanger sequencing. The assay is the firm's first clinical molecular diagnostic assay. Beckman, a Danaher company, added that it plans to develop additional CLIA-certified assays using next-generation sequencing for oncology and infectious disease applications.

"This certification allows Beckman Coulter to work more closely with physicians to bring the promise of high quality molecular diagnostics to benefit greater numbers of patients," Joseph Repp, vice president and general manager of Beckman Coulter Genomics, said in a statement. "We're actively working to bring additional assays to physicians and clinical researchers across the country, as well as help all our customers further their understanding of genetic involvement in disease states."

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.